Pharma News, 2020

Last September, Johnson & Johnson said prostate cancer med Erleada had “barely missed” showing it could extend the lives of patients with nonmetastatic castration-resistant disease.

Researchers from Bar-Ilan University have developed new methodologies to produce powerful, environmentally friendly disinfectants based on tap water that can eliminate bacteria and kill viruses, inclu...

Patients with follicular lymphoma will now get NHS-funded treatment with Roche's Gazyvaro (binutuzumab)/bendamustine in England and Wales after cost regulators published guidelines backing...

BEIJING, Xinhua -- Chinese researchers have identified a gene that is related to arterial aging in primates.

The National Institute for Health and Care Excellence (NICE) has published guidance recommending the use of Pfizer's Lorviqua (lorlatinib) for a certain form of lung cancer on the ...

A Stanford research team has developed a way to boost the effectiveness of the insulin injections people with diabetes routinely take to control their blood sugar.

The U.

NORTH CHICAGO, May 8, 2020 /PRNewswire/ -- AbbVie (NYSE.

Zydus Cadila, a global innovation driven healthcare company, announced that it is launching enzalutamide, a highly effective drug for the treatment of prostate cancer, under the brand name ‘Obnyx’...

Today, the U.

Even amid a pandemic, the Department of Justice isn’t giving up on its years-long generics price-fixing probe.

AstraZeneca and Merck’s Lynparza, in tandem with Roche’s Avastin, nabbed an FDA green light Friday to treat those women, and those with BRCA mutations, too.